Business Context and Reporting Period
This Form 8-K is a current report filed by AgeX Therapeutics, Inc. (not Serina Therapeutics, Inc.) on November 29, 2018. The registrant is a Delaware corporation headquartered in Alameda, California, and is designated as an emerging growth company. The filing serves to disclose a press release issued on the same date under Item 7.01 (Regulation FD Disclosure).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural report referencing an external press release (Exhibit 99.1) rather than a financial statement containing quantitative data.
Material Changes
No material financial changes or comparative period data are detailed within the body of this Form 8-K. The report indicates the issuance of a press release but does not summarize its contents regarding operational or financial shifts.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The filing includes a standard disclaimer that statements containing words such as "may," "will," "believes," or "expects" are forward-looking and subject to risks.
- Risk Factors: The document directs investors to the "Risk Factors" section of AgeX's periodic SEC reports for details on factors that could cause actual results to differ materially from anticipated results.
- Management Commentary: No specific management commentary or guidance is included in this text; the substantive disclosure is contained in the attached Exhibit 99.1.
Investor Verification Checklist
- Verify the contents of Exhibit 99.1 (Press Release dated November 29, 2018) for the actual details of the event being reported.
- Confirm the registrant name is AgeX Therapeutics, Inc. and not Serina Therapeutics, Inc.
- Review the company's most recent 10-K or 10-Q filings for the "Risk Factors" referenced in the forward-looking statements disclaimer.
- Note that this filing is deemed "furnished" and not "filed" under Section 18 of the Exchange Act, limiting its incorporation by reference into other filings.